These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7144290)

  • 1. [Membranous nephropathy caused by D-penicillamine].
    Prieto Carles C; Gutiérrez Millet V; Barrientos A; Bello I; Gómez Tierno A; Navas JJ; Rodicio JL
    Med Clin (Barc); 1982 Sep 1-15; 79(4):164-7. PubMed ID: 7144290
    [No Abstract]   [Full Text] [Related]  

  • 2. [Minimal lesion nephrotic syndrome following treatment with D-penicillamine].
    González C; Romero R; Requeséns C; Nogues R; Oliver A; Carreras M; Mauri J
    Rev Clin Esp; 1982 Feb; 164(3):207-9. PubMed ID: 7089341
    [No Abstract]   [Full Text] [Related]  

  • 3. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
    Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Membranous glomerulonephritis caused by D-penicillamine].
    Bécares Lozano MM; Pascual Izuel JM; Mateos Sánchez A; Delgado Martínez J; Querol Prieto R; Flores Corral T
    Rev Clin Esp; 1982 Mar; 164(6):411-2. PubMed ID: 7111809
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimal change nephropathy and pemphigus vulgaris associated with penicillamine treatment of rheumatoid arthritis.
    Savill JS; Chia Y; Pusey CD
    Clin Nephrol; 1988 May; 29(5):267-70. PubMed ID: 3396226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [D-penicillamine and glomerulonephritis].
    Altrogge G; Hofmann K; Huth F; Grabensee B; Schoppe WD
    Med Welt; 1976 Nov; 27(47):2282-3. PubMed ID: 1004174
    [No Abstract]   [Full Text] [Related]  

  • 7. D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.
    Bienaimé F; Clerbaux G; Plaisier E; Mougenot B; Ronco P; Rougier JP
    Am J Kidney Dis; 2007 Nov; 50(5):821-5. PubMed ID: 17954295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glomerulopathy due to D-penicillamine--clinical findings and renal biopsy].
    Brass H; Genth E; Hartl PW; Bauerdick H; Buss H; Lapp H; Heintz R
    Med Welt; 1976 Nov; 27(45):2151-3. PubMed ID: 994834
    [No Abstract]   [Full Text] [Related]  

  • 9. [Extramembranous glomerulonephritis induced by D-penicillamine. Description of a case].
    Miguel Donderis A; Sánchez Vegazo I; Gómez Campdera FJ; Gallego JL; Fernández Fernández J; Sanz Guajardo D; Botella J
    Rev Clin Esp; 1981 Jan; 160(2):137-8. PubMed ID: 7209061
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal biopsy appearances in rheumatoid disease.
    Sellars L; Siamopoulos K; Wilkinson R; Leohapand T; Morley AR
    Clin Nephrol; 1983 Sep; 20(3):114-20. PubMed ID: 6627762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrotic syndrome with minimal glomerular lesions during treatment with D-penicillamine].
    Herve JP; Leguy P; Cledes J; Leroy JP
    Nouv Presse Med; 1980 Oct; 9(38):2847. PubMed ID: 7443414
    [No Abstract]   [Full Text] [Related]  

  • 12. [D-penicillamine-induced lipoid nephrosis in a patient with scleroderma].
    Kitazawa K; Ohseto Y; Kawazumi H; Saito K; Shibata T; Uchida J; Yonekura M; Shiwachi S; Ito S; Sugisaki T
    Ryumachi; 1982 Oct; 22(5):397-403. PubMed ID: 7157094
    [No Abstract]   [Full Text] [Related]  

  • 13. Massive proteinuria for minimal change nephropathy secondary to treatment with D-penicilamine in a patient with Wilson's disease. Case report.
    Borrego García E; Hernández García E; Caba Molina M; Navas-Parejo Casado AM
    Gastroenterol Hepatol; 2020 Feb; 43(2):92-93. PubMed ID: 31810792
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipoid nephrosis of toxic origin. 2 cases].
    Belghiti D; Patey O; Berry JP; Antelin C; Hirbec G; Lagrue G
    Presse Med; 1986 Nov; 15(39):1953-5. PubMed ID: 2947217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arthritis due to Wilson disease, penicillamine, psoriasis or hepatocellular carcinoma? Blurred focus, sharp boundaries.
    Emlakçioglu E; Ozçakar L; Kaymak B; Bayraktar Y; Akinci A
    Acta Reumatol Port; 2009; 34(4):685-6. PubMed ID: 20087277
    [No Abstract]   [Full Text] [Related]  

  • 16. C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?
    Sturfelt G; Rydgren L; Truedsson L; Alm P; Sjöholm AG
    J Rheumatol; 1996 Feb; 23(2):378-81. PubMed ID: 8882051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membranous glomerulonephritis in rheumatoid arthritis not related to gold or D-penicillamine therapy: a report of four cases and review of the literature.
    Honkanen E; Törnroth T; Pettersson E; Skrifvars B
    Clin Nephrol; 1987 Feb; 27(2):87-93. PubMed ID: 3829481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glomerulopathy in rheumatic patients due to penicillamine].
    Muller V; Krumhaar I; Schneider W; Ditscherlein G
    Allerg Immunol (Leipz); 1976; 22(3):291-5. PubMed ID: 139094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracapillary glomerulonephritis with necrotizing vasculitis in D-penicillamine-treated rheumatoid arthritis.
    Banfi G; Imbasciati E; Guerra L; Mihatsch MJ; Ponticelli C
    Nephron; 1983; 33(1):56-60. PubMed ID: 6339966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal renal vasculitis and minimal change glomerulonephritis complicating treatment with penicillamine. Report on two cases.
    Falck HM; Törnroth T; Kock B; Wegelius O
    Acta Med Scand; 1979; 205(1-2):133-8. PubMed ID: 760401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.